Friday, August 6th, 2010 at
4:29 pm
Helix BioMedix Reports Second Quarter 2010 Financial Results
BOTHELL, Wash.–(BUSINESS WIRE)–Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s second quarter 2010 ended June 30, 2010. Second Quarter 2010 and Recent Highlights: Recorded record revenue of approximately $330,000 in the second quarter of 2010, compared to approximately $138,000 in the same period a year ago, an increase …
Read more on Business Wire
Friday, July 30th, 2010 at
6:58 am
Reliv International Reports Second-Quarter 2010 Results
News), a nutrition and direct selling company, today reported consolidated net sales of $18.8 million for the second quarter of 2010, compared to net sales of $20.1 million in the second quarter of last year. Â International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.
Read more on PR Newswire via Yahoo! Finance
Wednesday, June 9th, 2010 at
4:16 pm
Neiman Marcus Launches 37 Extreme Actives From Dr. Macrene Skin Results
Macrene Alexiades-Armenakas, M.D., Ph.D., F.A.A.D., the Manhattan based Derm-Scientist®, announced today that her brainchild, Dr. Macrene® Skin Results® 37 Extreme Actives® high performance anti-aging cream, is available nationwide as an exclusive at all 41 Neiman Marcus locations.
Read more on PR Newswire via Yahoo! Finance
